Media

Our latest news and articles

News

CPI appoints Hunada Nouss OBE as Non-Executive Director 

CPI appoints Hunada Nouss OBE as Non-Executive Director, boosting strategic governance to support UK innovation and growth. 

May 12 2026
News

Cambridge oncology innovator secures £500k investment to improve cancer drug development accuracy 

CPI Enterprises invests £500,000 in Verinnogen to advance novel technology for more accurate and reliable cancer drug development. 

May 11 2026
Blog

Seven steps from breakthrough to scale: the ingredients behind Pragmatic Semiconductor’s success 

How Pragmatic Semiconductor scaled from breakthrough to high‑volume manufacturing, with CPI enabling the journey through partnership, place and timing. 

Apr 30 2026
Blog

How does sustainable parchment paper perform in real baking environments? 

Can sustainable unbleached parchment paper match traditional performance? CPI tests real baking conditions for heat, non-stick and grease resistance. 

Apr 29 2026
News

CPI strengthens route to market for novel foods with expanded pilot-scale capability 

CPI’s expanded Novel Food Innovation Centre adds pilot-scale food bioprocessing to help novel foods scale from lab to UK manufacturing. 

Apr 28 2026
Blog

Genetic detection isn’t always clinical truth: why phenotypic AMR testing still matters 

Genes predict resistance, phenotype proves reality. Why phenotypic AMR testing remains essential for confident antibiotic decisions. 

Apr 24 2026
Blog

Innovation at scale: Overcoming the challenges of battery manufacturing 

Scaling next‑gen battery materials is a key challenge as innovators struggle to move from lab breakthroughs to reliable, industrial‑scale production. 

Mar 27 2026
News

UK launches £5 million next-generation cancer diagnostics programme to accelerate early detection and adoption 

UK launches £5m programme to speed next‑gen cancer diagnostics by uniting industry, clinicians, patients and tech leaders to advance early detection. 

Mar 24 2026
Blog

Purification is the bottleneck in oligonucleotide manufacturing. Can it be reinvented from scratch? 

As purification becomes the bottleneck in oligonucleotide manufacturing, how will the industry rethink scalable, cost‑effective production? 

Mar 18 2026
Next  
1 2 3 Next  

Page 1 of 106

CPI is your innovation partner to make your ideas a reality.